Table 3.
The effect of the MOTILIPERM on sperm motility and count of vas deferens, epididymis.
| CTR + vehicle | CTR + M 200 | VC + vehicle | VC + M 100 | VC + M 200 | |
|---|---|---|---|---|---|
| Motility (%) | |||||
| Vas deferens | 58.60 ± 08.57 | 55.72 ± 04.28 | 27.15 ± 17.14# | 45.70 ± 17.14 | 48.57 ± 08.57* |
| Epididymis | 51.42 ± 05.72 | 51.42 ± 04.29 | 25.71 ± 11.43# | 40.10 ± 19.90 | 47.14 ± 11.42* |
| Count (106/mL) | |||||
| Vas deferens | 24.28 ± 02.86 | 25.43 ± 07.14 | 14.28 ± 06.42# | 21.42 ± 12.14 | 25.00 ± 05.71* |
| Epididymis | 41.66 ± 03.33 | 40.83 ± 02.91 | 25.00 ± 05.83# | 30.83 ± 09.16 | 43.33 ± 06.66* |
CTR + vehicle: normal control group; CTR + M 200: normal rats administered 200 mg/kg MOTILIPERM; VC + vehicle: varicocele-induced rats; VC + M 100: varicocele-induced rats administered 100 mg/kg MOTILIPERM; VC + M 200: varicocele-induced rats administered 200 mg/kg MOTILIPERM.
Data are presented in mean ± SD.
#
Significantly different from CTR + vehicle group (p < 0.05).
*
Significantly different from VC + vehicle group (p < 0.05).